Detalhe da pesquisa
1.
Genomic Characterization of Preclinical Prostate Cancer Cell Line Models.
Int J Mol Sci
; 25(11)2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38892296
2.
PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA.
Oncologist
; 26(1): e115-e129, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32790034
3.
Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)n Repeat Polymorphism: Potential Clinical Consequences of Genotyping Errors?
Int J Mol Sci
; 21(3)2020 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019188
4.
Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
Cancer
; 122(15): 2332-40, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27164191
5.
Androgen receptor variation affects prostate cancer progression and drug resistance.
Pharmacol Res
; 114: 152-162, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27725309
6.
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
Mol Pharmacol
; 87(6): 1006-12, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25829060
7.
Genetic variation: effect on prostate cancer.
Biochim Biophys Acta
; 1846(2): 446-56, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25199985
8.
Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Mol Cancer
; 13: 91, 2014 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24775564
9.
Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer.
J Racial Ethn Health Disparities
; 11(1): 492-504, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810713
10.
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3.
J Cancer
; 15(3): 615-622, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213719
11.
Targeting the metastatic niche: Single-cell lineage tracing in prime time.
iScience
; 26(3): 106174, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895653
12.
GNRH2 Polymorphism in Men With Prostate Cancer Treated With Androgen Deprivation Therapy.
Anticancer Res
; 43(9): 4023-4030, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648321
13.
Racial disparities in the association between variants on 8q24 and prostate cancer: a systematic review and meta-analysis.
Oncologist
; 17(3): 312-20, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382457
14.
Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome.
Cancer Biol Ther
; 23(1): 136-138, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129066
15.
PARP inhibitors on the move in prostate cancer: spotlight on Niraparib & update on PARP inhibitor combination trials.
Am J Clin Exp Urol
; 10(4): 252-257, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051614
16.
Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.
Endocr Relat Cancer
; 29(2): 99-109, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889205
17.
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Cancer Causes Control
; 22(8): 1121-31, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21667068
18.
The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivity.
Mutat Res
; 708(1-2): 21-7, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21315089
19.
Diversity on demand: multi-ancestry meta-analysis improves genetic risk prediction in prostate cancer.
Am J Clin Exp Urol
; 9(2): 189-193, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079852
20.
Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models.
Mol Cancer Ther
; 20(5): 915-924, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632874